nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—IKBKB—Auranofin—psoriatic arthritis	0.663	0.781	CbGbCtD
Arsenic trioxide—CYP1B1—Dexamethasone—psoriatic arthritis	0.0363	0.0428	CbGbCtD
Arsenic trioxide—ABCC2—Dexamethasone—psoriatic arthritis	0.0191	0.0225	CbGbCtD
Arsenic trioxide—ABCB1—Methylprednisolone—psoriatic arthritis	0.0165	0.0194	CbGbCtD
Arsenic trioxide—CYP1A1—Dexamethasone—psoriatic arthritis	0.0159	0.0188	CbGbCtD
Arsenic trioxide—ABCC2—Methotrexate—psoriatic arthritis	0.0154	0.0181	CbGbCtD
Arsenic trioxide—ABCB1—Betamethasone—psoriatic arthritis	0.0107	0.0126	CbGbCtD
Arsenic trioxide—ABCB1—Prednisolone—psoriatic arthritis	0.0106	0.0125	CbGbCtD
Arsenic trioxide—ABCB1—Prednisone—psoriatic arthritis	0.00998	0.0118	CbGbCtD
Arsenic trioxide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.00987	0.0116	CbGbCtD
Arsenic trioxide—CYP3A4—Triamcinolone—psoriatic arthritis	0.00748	0.00882	CbGbCtD
Arsenic trioxide—CYP3A4—Betamethasone—psoriatic arthritis	0.00642	0.00756	CbGbCtD
Arsenic trioxide—CYP3A4—Prednisolone—psoriatic arthritis	0.00633	0.00746	CbGbCtD
Arsenic trioxide—ABCB1—Dexamethasone—psoriatic arthritis	0.00623	0.00734	CbGbCtD
Arsenic trioxide—CYP3A4—Prednisone—psoriatic arthritis	0.00598	0.00705	CbGbCtD
Arsenic trioxide—ABCB1—Methotrexate—psoriatic arthritis	0.00501	0.0059	CbGbCtD
Arsenic trioxide—CYP3A4—Dexamethasone—psoriatic arthritis	0.00373	0.0044	CbGbCtD
Arsenic trioxide—CCND1—skin of body—psoriatic arthritis	0.00151	0.103	CbGeAlD
Arsenic trioxide—MAPK1—skin of body—psoriatic arthritis	0.00128	0.0865	CbGeAlD
Arsenic trioxide—TXNRD1—skin of body—psoriatic arthritis	0.00119	0.0805	CbGeAlD
Arsenic trioxide—CCND1—tendon—psoriatic arthritis	0.00115	0.0781	CbGeAlD
Arsenic trioxide—MAPK3—skin of body—psoriatic arthritis	0.00113	0.0765	CbGeAlD
Arsenic trioxide—AKT1—skin of body—psoriatic arthritis	0.00107	0.0722	CbGeAlD
Arsenic trioxide—JUN—skin of body—psoriatic arthritis	0.000927	0.0628	CbGeAlD
Arsenic trioxide—IKBKB—skin of body—psoriatic arthritis	0.000923	0.0625	CbGeAlD
Arsenic trioxide—TXNRD1—tendon—psoriatic arthritis	0.000904	0.0613	CbGeAlD
Arsenic trioxide—MAPK3—tendon—psoriatic arthritis	0.00086	0.0583	CbGeAlD
Arsenic trioxide—AKT1—tendon—psoriatic arthritis	0.000811	0.0549	CbGeAlD
Arsenic trioxide—JUN—tendon—psoriatic arthritis	0.000706	0.0478	CbGeAlD
Arsenic trioxide—IKBKB—tendon—psoriatic arthritis	0.000702	0.0476	CbGeAlD
Arsenic trioxide—CYP1B1—skin of body—psoriatic arthritis	0.000494	0.0335	CbGeAlD
Arsenic trioxide—ABCC2—tendon—psoriatic arthritis	0.000384	0.026	CbGeAlD
Arsenic trioxide—CYP1B1—tendon—psoriatic arthritis	0.000376	0.0255	CbGeAlD
Arsenic trioxide—MAPK1—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.000363	0.00276	CbGpPWpGaD
Arsenic trioxide—JUN—MyD88-independent cascade—NOD2—psoriatic arthritis	0.000362	0.00275	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular roles of Anthrax toxin—TNF—psoriatic arthritis	0.000362	0.00275	CbGpPWpGaD
Arsenic trioxide—MAPK1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—psoriatic arthritis	0.00036	0.00273	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Selenium Micronutrient Network—TNF—psoriatic arthritis	0.000359	0.00273	CbGpPWpGaD
Arsenic trioxide—MAPK3—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.000358	0.00272	CbGpPWpGaD
Arsenic trioxide—JUN—ATF-2 transcription factor network—NOS2—psoriatic arthritis	0.000355	0.0027	CbGpPWpGaD
Arsenic trioxide—MAPK1—MyD88 dependent cascade initiated on endosome—NOD2—psoriatic arthritis	0.000353	0.00268	CbGpPWpGaD
Arsenic trioxide—MAPK3—MyD88:Mal cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.000352	0.00268	CbGpPWpGaD
Arsenic trioxide—CYP1A1—skin of body—psoriatic arthritis	0.000349	0.0237	CbGeAlD
Arsenic trioxide—IKBKB—MyD88 cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.000347	0.00264	CbGpPWpGaD
Arsenic trioxide—IKBKB—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.000347	0.00264	CbGpPWpGaD
Arsenic trioxide—MAPK1—Type II diabetes mellitus—TNF—psoriatic arthritis	0.000344	0.00262	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular roles of Anthrax toxin—TNF—psoriatic arthritis	0.000344	0.00262	CbGpPWpGaD
Arsenic trioxide—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—psoriatic arthritis	0.000344	0.00262	CbGpPWpGaD
Arsenic trioxide—MAPK1—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.000341	0.00259	CbGpPWpGaD
Arsenic trioxide—JUN—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.00034	0.00259	CbGpPWpGaD
Arsenic trioxide—AKT1—Downstream signaling events of B Cell Receptor (BCR)—REL—psoriatic arthritis	0.000339	0.00257	CbGpPWpGaD
Arsenic trioxide—IKBKB—MyD88 dependent cascade initiated on endosome—NOD2—psoriatic arthritis	0.000338	0.00257	CbGpPWpGaD
Arsenic trioxide—MAPK3—MyD88-independent cascade—NOD2—psoriatic arthritis	0.000338	0.00257	CbGpPWpGaD
Arsenic trioxide—MAPK1—MyD88:Mal cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.000335	0.00255	CbGpPWpGaD
Arsenic trioxide—MAPK1—EBV LMP1 signaling—TNF—psoriatic arthritis	0.000332	0.00253	CbGpPWpGaD
Arsenic trioxide—MAPK3—ATF-2 transcription factor network—NOS2—psoriatic arthritis	0.000331	0.00252	CbGpPWpGaD
Arsenic trioxide—IKBKB—Type II diabetes mellitus—TNF—psoriatic arthritis	0.000329	0.0025	CbGpPWpGaD
Arsenic trioxide—AKT1—TCR signaling in naïve CD4+ T cells—HLA-DRB1—psoriatic arthritis	0.000328	0.00249	CbGpPWpGaD
Arsenic trioxide—JUN—Activated TLR4 signalling—NOD2—psoriatic arthritis	0.000326	0.00248	CbGpPWpGaD
Arsenic trioxide—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.000326	0.00248	CbGpPWpGaD
Arsenic trioxide—JUN—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.000325	0.00247	CbGpPWpGaD
Arsenic trioxide—JUN—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	0.000325	0.00247	CbGpPWpGaD
Arsenic trioxide—MAPK1—MyD88-independent cascade—NOD2—psoriatic arthritis	0.000321	0.00244	CbGpPWpGaD
Arsenic trioxide—IKBKB—MyD88:Mal cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.00032	0.00244	CbGpPWpGaD
Arsenic trioxide—AKT1—Costimulation by the CD28 family—HLA-DRB1—psoriatic arthritis	0.00032	0.00243	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.000319	0.00243	CbGpPWpGaD
Arsenic trioxide—IKBKB—EBV LMP1 signaling—TNF—psoriatic arthritis	0.000318	0.00242	CbGpPWpGaD
Arsenic trioxide—IKBKB—Canonical NF-kappaB pathway—TNF—psoriatic arthritis	0.000318	0.00242	CbGpPWpGaD
Arsenic trioxide—IKBKB—TCR signaling—HLA-DRB1—psoriatic arthritis	0.000317	0.00241	CbGpPWpGaD
Arsenic trioxide—MAPK1—ATF-2 transcription factor network—NOS2—psoriatic arthritis	0.000315	0.0024	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by Interleukins—NOD2—psoriatic arthritis	0.000315	0.00239	CbGpPWpGaD
Arsenic trioxide—AKT1—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.000312	0.00237	CbGpPWpGaD
Arsenic trioxide—AKT1—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	0.000312	0.00237	CbGpPWpGaD
Arsenic trioxide—AKT1—Rac1/Pak1/p38/MMP-2 pathway—NOS2—psoriatic arthritis	0.000308	0.00234	CbGpPWpGaD
Arsenic trioxide—IKBKB—MyD88-independent cascade—NOD2—psoriatic arthritis	0.000307	0.00234	CbGpPWpGaD
Arsenic trioxide—AKT1—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.000307	0.00233	CbGpPWpGaD
Arsenic trioxide—JUN—Toll Like Receptor 4 (TLR4) Cascade—NOD2—psoriatic arthritis	0.000307	0.00233	CbGpPWpGaD
Arsenic trioxide—MAPK3—Activated TLR4 signalling—NOD2—psoriatic arthritis	0.000304	0.00231	CbGpPWpGaD
Arsenic trioxide—MAPK3—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.000303	0.0023	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by Interleukins—NOD2—psoriatic arthritis	0.0003	0.00228	CbGpPWpGaD
Arsenic trioxide—MAPK3—Interferon Signaling—HLA-C—psoriatic arthritis	0.000299	0.00228	CbGpPWpGaD
Arsenic trioxide—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—NOS2—psoriatic arthritis	0.000299	0.00227	CbGpPWpGaD
Arsenic trioxide—AKT1—B Cell Activation—REL—psoriatic arthritis	0.000299	0.00227	CbGpPWpGaD
Arsenic trioxide—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—REL—psoriatic arthritis	0.000299	0.00227	CbGpPWpGaD
Arsenic trioxide—MAPK3—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.000298	0.00226	CbGpPWpGaD
Arsenic trioxide—AKT1—DAP12 interactions—HLA-C—psoriatic arthritis	0.000297	0.00226	CbGpPWpGaD
Arsenic trioxide—IKBKB—TCR signaling in naïve CD4+ T cells—HLA-DRB1—psoriatic arthritis	0.000289	0.0022	CbGpPWpGaD
Arsenic trioxide—MAPK1—Activated TLR4 signalling—NOD2—psoriatic arthritis	0.000289	0.0022	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 interactions—HLA-C—psoriatic arthritis	0.000288	0.00219	CbGpPWpGaD
Arsenic trioxide—MAPK1—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.000288	0.00219	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by Interleukins—NOD2—psoriatic arthritis	0.000287	0.00218	CbGpPWpGaD
Arsenic trioxide—MAPK3—Toll Like Receptor 4 (TLR4) Cascade—NOD2—psoriatic arthritis	0.000286	0.00217	CbGpPWpGaD
Arsenic trioxide—MAPK1—Rac1/Pak1/p38/MMP-2 pathway—NOS2—psoriatic arthritis	0.000285	0.00216	CbGpPWpGaD
Arsenic trioxide—MAPK1—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.000283	0.00215	CbGpPWpGaD
Arsenic trioxide—IKBKB—Activated TLR4 signalling—NOD2—psoriatic arthritis	0.000277	0.0021	CbGpPWpGaD
Arsenic trioxide—IKBKB—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.000276	0.00209	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 interactions—HLA-C—psoriatic arthritis	0.000274	0.00209	CbGpPWpGaD
Arsenic trioxide—JUN—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.000273	0.00208	CbGpPWpGaD
Arsenic trioxide—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NOS2—psoriatic arthritis	0.000272	0.00207	CbGpPWpGaD
Arsenic trioxide—MAPK1—Toll Like Receptor 4 (TLR4) Cascade—NOD2—psoriatic arthritis	0.000272	0.00207	CbGpPWpGaD
Arsenic trioxide—IKBKB—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.000271	0.00206	CbGpPWpGaD
Arsenic trioxide—AKT1—CXCR4-mediated signaling events—HLA-DRB1—psoriatic arthritis	0.00027	0.00205	CbGpPWpGaD
Arsenic trioxide—IKBKB—B Cell Activation—REL—psoriatic arthritis	0.000264	0.00201	CbGpPWpGaD
Arsenic trioxide—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—NOD2—psoriatic arthritis	0.00026	0.00198	CbGpPWpGaD
Arsenic trioxide—MAPK3—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.000254	0.00193	CbGpPWpGaD
Arsenic trioxide—MAPK1—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.000242	0.00184	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—MEFV—psoriatic arthritis	0.000235	0.00179	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—HLA-C—psoriatic arthritis	0.000232	0.00176	CbGpPWpGaD
Arsenic trioxide—IKBKB—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.000232	0.00176	CbGpPWpGaD
Arsenic trioxide—JUN—FAS pathway and Stress induction of HSP regulation—TNF—psoriatic arthritis	0.000232	0.00176	CbGpPWpGaD
Arsenic trioxide—JUN—TWEAK Signaling Pathway—TNF—psoriatic arthritis	0.000232	0.00176	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—IL13—psoriatic arthritis	0.00023	0.00175	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—MEFV—psoriatic arthritis	0.000226	0.00172	CbGpPWpGaD
Arsenic trioxide—AKT1—TWEAK Signaling Pathway—TNF—psoriatic arthritis	0.000222	0.00169	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—MEFV—psoriatic arthritis	0.000219	0.00166	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Flunisolide—Methylprednisolone—psoriatic arthritis	0.000219	0.041	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.000216	0.0405	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Methylprednisolone—psoriatic arthritis	0.000216	0.0405	CbGdCrCtD
Arsenic trioxide—MAPK3—TWEAK Signaling Pathway—TNF—psoriatic arthritis	0.000216	0.00164	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Flunisolide—Betamethasone—psoriatic arthritis	0.000215	0.0404	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Dexamethasone—psoriatic arthritis	0.000215	0.0404	CbGdCrCtD
Arsenic trioxide—JUN—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000215	0.00164	CbGpPWpGaD
Arsenic trioxide—JUN—Betamethasone—Dexamethasone—psoriatic arthritis	0.000212	0.0398	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Betamethasone—psoriatic arthritis	0.000212	0.0398	CbGdCrCtD
Arsenic trioxide—ABCB1—Allograft Rejection—IL17A—psoriatic arthritis	0.000212	0.00161	CbGpPWpGaD
Arsenic trioxide—CCND1—Spinal Cord Injury—TNF—psoriatic arthritis	0.000212	0.00161	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.000211	0.0396	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Triamcinolone—psoriatic arthritis	0.00021	0.0394	CbGdCrCtD
Arsenic trioxide—MAPK1—Innate Immune System—MEFV—psoriatic arthritis	0.000208	0.00158	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.000208	0.0389	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.000208	0.0389	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Triamcinolone—psoriatic arthritis	0.000208	0.0389	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Triamcinolone—psoriatic arthritis	0.000208	0.0389	CbGdCrCtD
Arsenic trioxide—MAPK1—TWEAK Signaling Pathway—TNF—psoriatic arthritis	0.000205	0.00156	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.000203	0.0381	CbGdCrCtD
Arsenic trioxide—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriatic arthritis	0.000201	0.00153	CbGpPWpGaD
Arsenic trioxide—AKT1—Ceramide signaling pathway—TNF—psoriatic arthritis	0.0002	0.00152	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—HLA-C—psoriatic arthritis	0.0002	0.00152	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Flunisolide—Prednisone—psoriatic arthritis	0.0002	0.0374	CbGdCrCtD
Arsenic trioxide—IKBKB—Innate Immune System—MEFV—psoriatic arthritis	0.000199	0.00152	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—IL12B—psoriatic arthritis	0.000197	0.0015	CbGpPWpGaD
Arsenic trioxide—JUN—Betamethasone—Prednisone—psoriatic arthritis	0.000197	0.0369	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Prednisone—psoriatic arthritis	0.000197	0.0369	CbGdCrCtD
Arsenic trioxide—IKBKB—TWEAK Signaling Pathway—TNF—psoriatic arthritis	0.000196	0.00149	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Flunisolide—Prednisolone—psoriatic arthritis	0.000195	0.0365	CbGdCrCtD
Arsenic trioxide—MAPK3—Ceramide signaling pathway—TNF—psoriatic arthritis	0.000194	0.00147	CbGpPWpGaD
Arsenic trioxide—AKT1—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriatic arthritis	0.000193	0.00147	CbGpPWpGaD
Arsenic trioxide—JUN—Betamethasone—Prednisolone—psoriatic arthritis	0.000192	0.036	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Prednisolone—psoriatic arthritis	0.000192	0.036	CbGdCrCtD
Arsenic trioxide—MAPK1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000191	0.00145	CbGpPWpGaD
Arsenic trioxide—MAPK3—Spinal Cord Injury—NOS2—psoriatic arthritis	0.00019	0.00145	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—HLA-C—psoriatic arthritis	0.00019	0.00145	CbGpPWpGaD
Arsenic trioxide—JUN—TGF-beta Receptor Signaling—TNF—psoriatic arthritis	0.000189	0.00144	CbGpPWpGaD
Arsenic trioxide—MAPK3—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriatic arthritis	0.000188	0.00143	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—psoriatic arthritis	0.000185	0.0014	CbGpPWpGaD
Arsenic trioxide—MAPK1—Ceramide signaling pathway—TNF—psoriatic arthritis	0.000184	0.0014	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Testosterone—Prednisolone—psoriatic arthritis	0.000184	0.0345	CbGdCrCtD
Arsenic trioxide—IKBKB—TNF receptor signaling pathway —TNF—psoriatic arthritis	0.000183	0.00139	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—HLA-C—psoriatic arthritis	0.000182	0.00138	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—NOS2—psoriatic arthritis	0.000181	0.00138	CbGpPWpGaD
Arsenic trioxide—AKT1—Cardiac Hypertrophic Response—TNF—psoriatic arthritis	0.000179	0.00136	CbGpPWpGaD
Arsenic trioxide—MAPK1—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriatic arthritis	0.000179	0.00136	CbGpPWpGaD
Arsenic trioxide—MAPK3—Interferon Signaling—HLA-B—psoriatic arthritis	0.000177	0.00135	CbGpPWpGaD
Arsenic trioxide—MAPK3—TGF-beta Receptor Signaling—TNF—psoriatic arthritis	0.000176	0.00134	CbGpPWpGaD
Arsenic trioxide—AKT1—DAP12 interactions—HLA-B—psoriatic arthritis	0.000176	0.00134	CbGpPWpGaD
Arsenic trioxide—AKT1—Caspase Cascade in Apoptosis—TNF—psoriatic arthritis	0.000174	0.00132	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cardiac Hypertrophic Response—TNF—psoriatic arthritis	0.000174	0.00132	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000172	0.00131	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000172	0.00131	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 interactions—HLA-B—psoriatic arthritis	0.000171	0.0013	CbGpPWpGaD
Arsenic trioxide—MAPK1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—psoriatic arthritis	0.00017	0.0013	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cardiac Hypertrophic Response—TNF—psoriatic arthritis	0.000165	0.00126	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 interactions—HLA-B—psoriatic arthritis	0.000162	0.00123	CbGpPWpGaD
Arsenic trioxide—JUN—Downstream signaling in naïve CD8+ T cells—TNF—psoriatic arthritis	0.000161	0.00123	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cardiac Hypertrophic Response—TNF—psoriatic arthritis	0.000158	0.0012	CbGpPWpGaD
Arsenic trioxide—MAPK3—Downstream signaling in naïve CD8+ T cells—TNF—psoriatic arthritis	0.00015	0.00114	CbGpPWpGaD
Arsenic trioxide—MAPK3—Interferon Signaling—HLA-DRB1—psoriatic arthritis	0.00015	0.00114	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—NOD2—psoriatic arthritis	0.000147	0.00112	CbGpPWpGaD
Arsenic trioxide—CCND1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	0.000144	0.0011	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signaling in naïve CD8+ T cells—TNF—psoriatic arthritis	0.000143	0.00109	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—NOD2—psoriatic arthritis	0.00014	0.00106	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—HLA-B—psoriatic arthritis	0.000137	0.00104	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—MEFV—psoriatic arthritis	0.000137	0.00104	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—NOD2—psoriatic arthritis	0.000134	0.00102	CbGpPWpGaD
Arsenic trioxide—JUN—Circadian rythm related genes—NOS2—psoriatic arthritis	0.000133	0.00101	CbGpPWpGaD
Arsenic trioxide—JUN—Apoptosis—TNF—psoriatic arthritis	0.000133	0.00101	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—MEFV—psoriatic arthritis	0.000131	0.000999	CbGpPWpGaD
Arsenic trioxide—MAPK3—Alzheimers Disease—TNF—psoriatic arthritis	0.00013	0.000989	CbGpPWpGaD
Arsenic trioxide—AKT1—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.000128	0.000971	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis—TNF—psoriatic arthritis	0.000128	0.000971	CbGpPWpGaD
Arsenic trioxide—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	0.000128	0.00097	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—MEFV—psoriatic arthritis	0.000128	0.000969	CbGpPWpGaD
Arsenic trioxide—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.000124	0.000942	CbGpPWpGaD
Arsenic trioxide—MAPK1—Alzheimers Disease—TNF—psoriatic arthritis	0.000124	0.000941	CbGpPWpGaD
Arsenic trioxide—JUN—TNF alpha Signaling Pathway—TNF—psoriatic arthritis	0.000124	0.00094	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—MEFV—psoriatic arthritis	0.000121	0.000922	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—REL—psoriatic arthritis	0.000121	0.000917	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—HLA-C—psoriatic arthritis	0.00012	0.000914	CbGpPWpGaD
Arsenic trioxide—AKT1—TNF alpha Signaling Pathway—TNF—psoriatic arthritis	0.000119	0.000903	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	0.000118	0.000898	CbGpPWpGaD
Arsenic trioxide—MAPK1—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.000118	0.000896	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—MEFV—psoriatic arthritis	0.000116	0.000882	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—HLA-DRB1—psoriatic arthritis	0.000116	0.000882	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—HLA-C—psoriatic arthritis	0.000116	0.000878	CbGpPWpGaD
Arsenic trioxide—MAPK3—TNF alpha Signaling Pathway—TNF—psoriatic arthritis	0.000115	0.000876	CbGpPWpGaD
Arsenic trioxide—JUN—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.000114	0.000865	CbGpPWpGaD
Arsenic trioxide—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.000113	0.000857	CbGpPWpGaD
Arsenic trioxide—IKBKB—Apoptosis—TNF—psoriatic arthritis	0.000113	0.000857	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	0.000112	0.000855	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—HLA-C—psoriatic arthritis	0.000112	0.000852	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—HLA-C—psoriatic arthritis	0.000111	0.000844	CbGpPWpGaD
Arsenic trioxide—MAPK1—TNF alpha Signaling Pathway—TNF—psoriatic arthritis	0.00011	0.000833	CbGpPWpGaD
Arsenic trioxide—AKT1—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.000109	0.000831	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	0.000108	0.000818	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.000107	0.0201	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Methylprednisolone—psoriatic arthritis	0.000107	0.0201	CbGdCrCtD
Arsenic trioxide—MAPK1—Innate Immune System—HLA-C—psoriatic arthritis	0.000107	0.000811	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—REL—psoriatic arthritis	0.000106	0.000809	CbGpPWpGaD
Arsenic trioxide—MAPK3—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.000106	0.000806	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000106	0.000805	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000106	0.000805	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Betamethasone—Dexamethasone—psoriatic arthritis	0.000105	0.0197	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Betamethasone—psoriatic arthritis	0.000105	0.0197	CbGdCrCtD
Arsenic trioxide—IKBKB—TNF alpha Signaling Pathway—TNF—psoriatic arthritis	0.000105	0.000797	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Dexamethasone—Triamcinolone—psoriatic arthritis	0.000103	0.0193	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Triamcinolone—psoriatic arthritis	0.000103	0.0193	CbGdCrCtD
Arsenic trioxide—IKBKB—Innate Immune System—HLA-C—psoriatic arthritis	0.000102	0.000776	CbGpPWpGaD
Arsenic trioxide—MAPK1—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.000101	0.000767	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	0.0001	0.000761	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HLA-C—psoriatic arthritis	9.8e-05	0.000745	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Betamethasone—Prednisone—psoriatic arthritis	9.77e-05	0.0183	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Prednisone—psoriatic arthritis	9.77e-05	0.0183	CbGdCrCtD
Arsenic trioxide—IKBKB—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	9.66e-05	0.000734	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Dexamethasone—Prednisolone—psoriatic arthritis	9.53e-05	0.0179	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Prednisolone—psoriatic arthritis	9.53e-05	0.0179	CbGdCrCtD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	9.52e-05	0.000724	CbGpPWpGaD
Arsenic trioxide—MAPK3—Spinal Cord Injury—TNF—psoriatic arthritis	9.44e-05	0.000718	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	9.11e-05	0.000692	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—TNF—psoriatic arthritis	8.98e-05	0.000683	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	8.89e-05	0.000676	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—NOD2—psoriatic arthritis	8.85e-05	0.000672	CbGpPWpGaD
Arsenic trioxide—AKT1—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	8.54e-05	0.000649	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—NOD2—psoriatic arthritis	8.5e-05	0.000646	CbGpPWpGaD
Arsenic trioxide—MAPK3—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	8.28e-05	0.00063	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—NOD2—psoriatic arthritis	8.24e-05	0.000627	CbGpPWpGaD
Arsenic trioxide—JUN—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	8.1e-05	0.000616	CbGpPWpGaD
Arsenic trioxide—MAPK1—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	7.88e-05	0.000599	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—NOD2—psoriatic arthritis	7.84e-05	0.000596	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis—TNF—psoriatic arthritis	7.83e-05	0.000595	CbGpPWpGaD
Arsenic trioxide—JUN—MAPK Signaling Pathway—TNF—psoriatic arthritis	7.64e-05	0.000581	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—REL—psoriatic arthritis	7.61e-05	0.000579	CbGpPWpGaD
Arsenic trioxide—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	7.54e-05	0.000573	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—NOD2—psoriatic arthritis	7.5e-05	0.00057	CbGpPWpGaD
Arsenic trioxide—AKT1—MAPK Signaling Pathway—TNF—psoriatic arthritis	7.34e-05	0.000558	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—REL—psoriatic arthritis	7.31e-05	0.000556	CbGpPWpGaD
Arsenic trioxide—MAPK3—MAPK Signaling Pathway—TNF—psoriatic arthritis	7.12e-05	0.000541	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—HLA-B—psoriatic arthritis	7.11e-05	0.000541	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—REL—psoriatic arthritis	7.09e-05	0.000539	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HLA-C—psoriatic arthritis	7.01e-05	0.000533	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	6.89e-05	0.000524	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—HLA-B—psoriatic arthritis	6.83e-05	0.000519	CbGpPWpGaD
Arsenic trioxide—MAPK1—MAPK Signaling Pathway—TNF—psoriatic arthritis	6.77e-05	0.000515	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—REL—psoriatic arthritis	6.75e-05	0.000513	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-C—psoriatic arthritis	6.73e-05	0.000512	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—HLA-B—psoriatic arthritis	6.63e-05	0.000504	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	6.62e-05	0.000503	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—HLA-B—psoriatic arthritis	6.56e-05	0.000499	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-C—psoriatic arthritis	6.53e-05	0.000496	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—TNF—psoriatic arthritis	6.48e-05	0.000492	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—REL—psoriatic arthritis	6.46e-05	0.000491	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	6.42e-05	0.000488	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—HLA-B—psoriatic arthritis	6.31e-05	0.000479	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CRP—psoriatic arthritis	6.29e-05	0.000478	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-C—psoriatic arthritis	6.21e-05	0.000472	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—NOS2—psoriatic arthritis	6.12e-05	0.000465	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	6.11e-05	0.000465	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CRP—psoriatic arthritis	6.04e-05	0.000459	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—HLA-B—psoriatic arthritis	6.03e-05	0.000459	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-C—psoriatic arthritis	5.94e-05	0.000452	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—NOS2—psoriatic arthritis	5.93e-05	0.000451	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CRP—psoriatic arthritis	5.86e-05	0.000445	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HLA-B—psoriatic arthritis	5.79e-05	0.00044	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—NOS2—psoriatic arthritis	5.65e-05	0.000429	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CRP—psoriatic arthritis	5.57e-05	0.000424	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	5.55e-05	0.000422	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—TNF—psoriatic arthritis	5.49e-05	0.000417	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CRP—psoriatic arthritis	5.33e-05	0.000405	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—NOD2—psoriatic arthritis	5.15e-05	0.000392	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—NOD2—psoriatic arthritis	4.95e-05	0.000376	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	4.9e-05	0.000373	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—NOD2—psoriatic arthritis	4.8e-05	0.000365	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—NOD2—psoriatic arthritis	4.57e-05	0.000347	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—NOD2—psoriatic arthritis	4.37e-05	0.000332	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HLA-B—psoriatic arthritis	4.14e-05	0.000315	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-B—psoriatic arthritis	3.98e-05	0.000303	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-B—psoriatic arthritis	3.86e-05	0.000293	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-B—psoriatic arthritis	3.67e-05	0.000279	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CRP—psoriatic arthritis	3.66e-05	0.000278	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CRP—psoriatic arthritis	3.52e-05	0.000267	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-B—psoriatic arthritis	3.51e-05	0.000267	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HLA-DRB1—psoriatic arthritis	3.51e-05	0.000267	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CRP—psoriatic arthritis	3.41e-05	0.000259	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-DRB1—psoriatic arthritis	3.37e-05	0.000256	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-DRB1—psoriatic arthritis	3.27e-05	0.000248	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CRP—psoriatic arthritis	3.25e-05	0.000247	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-DRB1—psoriatic arthritis	3.11e-05	0.000236	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CRP—psoriatic arthritis	3.11e-05	0.000236	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TNF—psoriatic arthritis	3.1e-05	0.000235	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TNF—psoriatic arthritis	3e-05	0.000228	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-DRB1—psoriatic arthritis	2.97e-05	0.000226	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—NOS2—psoriatic arthritis	2.96e-05	0.000225	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NOS2—psoriatic arthritis	2.87e-05	0.000218	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TNF—psoriatic arthritis	2.86e-05	0.000217	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NOS2—psoriatic arthritis	2.73e-05	0.000208	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	2.71e-05	0.000206	CbGpPWpGaD
